market informationour common stock is traded on the new york stock exchange nyse under the symbol bsx the following table provides the market range for the closing price of our common stock for each of the last eight quarters based on reported sales prices on the nyse2013 high lowfirst quarter 781 589second quarter 964 709third quarter 1199 915fourth quarter 1238 1118     2012    first quarter 636 530second quarter 631 551third quarter 582 497fourth quarter 582 507holdersthe closing price of our common stock on january 31 2014 was 1353 as of january 31 2014 there were 13534 holders of record of our common stockdividendswe did not pay a cash dividend in 2013 or 2012 and currently do not intend to pay cash dividends we may consider declaring and paying a cash dividend in the future however there can be no assurance that we will do sosecurities authorized for issuance under equity compensation plansplease see item 12 security ownership of certain beneficial owners and management and related stockholder matters under part iii of this annual report for information on where to find information required by item 201d of regulation sk 33purchases of equity securities by the issuer and affiliated purchasesduring 2013 we used 500 million of cash generated from operations to repurchase approximately 51 million shares of our common stock pursuant to our share repurchase authorizations and during 2012 we used 600 million of cash generated from operations to repurchase approximately 105 million shares of our common stock pursuant to our share repurchase authorizations discussed in note l  stockholders equity to our 2013 consolidated financial statements contained in item 8 of this annual reportthe following table provides information with respect to purchases by boston scientific corporation of equity securities that are registered by us pursuant to section 12 of the exchange act during the fourth quarter of 2013periodtotal number of shares purchasedaverage price paid per sharetotal number of shares purchased as part of publicly announced plans or programs approximate dollar value of shares that may yet be purchased under the plans or programs 100113  103113420000011734200000835205581110113  11301314750093118914750093659535953120113  123113659535953 total18950093118518950093659535953      on july 28 2011 we announced that our board of directors had approved a program authorizing the repurchase of up to 10 billion of our common stock and reapproved approximately 37 million shares remaining under our previous share repurchase program as of december 31 2013 we had no remaining authorization available under our 2011 share repurchase program or previous repurchase programson january 25 2013 our board of directors approved a new program authorizing the repurchase of up to 10 billion of our common stock as of december 31 2013 we had approximately 660 million remaining available under the 2013 share repurchase programsale of unregistered securitiesbetween january 9 2013 and february 26 2013 inclusive ten employees purchased 190 shares of our common stock for 1328 the offering price per share on each date was the last reported sale price of our common stock on that date as reported on the nyse the issuance of such shares was pursuant to an exemption from the registration requirements of the securities act pursuant to section 42 of the securities act 34stock performance graphthe graph below compares the fiveyear total return to stockholders on our common stock with the return of the standard amp poors sampp 500 stock index and the sampp health care equipment index the graph assumes 100 was invested in our common stock and in each of the named indices on december 31 2008 and that all dividends were reinvestednote the stock price performance shown on the graph above is not indicative of future price performance this graph shall not be deemed filed for purposes of section18 of the exchange act or otherwise subject to the liabilities of that section nor shall it be deemed incorporated by reference in any filing under the securities act or the exchange act regardless of any general incorporation language in such filing  35